Page 121 - Ciences News Today

VERNON, British Columbia, Jan. 23, 2023 /PRNewswire/ -- Doseology Sciences Inc. (CSE: MOOD) (OTCQB: DOSEF) (FSE: VU7) ("Doseology" or the "Company"), a life sciences company focused on mental

NORTHAMPTON, MA / ACCESSWIRE / January 19, 2023 / Dr. Hila Elinav burst into tears of joy when the Israeli Ministry of Health announced a sweeping new HIV screening policy for pregnant women in September."It

Following the Government of Colombia's decision on insurance coverage for medical cannabis, Khiron has begun dispensing medical cannabis to its patient base under the new mandate.TORONTO, Jan.

Urovant Sciences, Inc., and Holly Robinson Peete Collaborate to Bring Awareness to Overactive Bladder (OAB) Symptoms and Management Options as Part of the Time To Go Campaign Holly Robinson

🔥 Compatibility To confirm that this part fits your vehicle, please enter your vehicles details below. ...<br>

Indias Health Minister Mansukh Mandaviya on Wednesday lauded the efforts of life sciences organisations during the Covid-19 pandemic in a Round Table on R&D and Innovation Opportunities in Life Sciences Sector at Davos.

Dr. Garibaldi's 40 years of experience brings industry-leading pharmaceuticals development expertise to the Scientific Board of Advisors.His appointment demonstrates the company's resolve to leverage

GL Sciences has released an upgrade to their CryoFocus 4. Click to read more...

The University of Louisiana Monroe Master of Occupational Therapy Program was recently granted full accreditation by the Accreditation Council on Occupational Therapy Education (ACOTE) during its December 2022 meeting. The accreditation comes after a year-long self-study process and an on-site review by ACOTE in August 2022. The ULM MOT program received the maximum accreditation level of 10 years, indicating that the program showed “no areas of noncompliance” and “demonstrated exceptional ...

Terrence West, MBA, joins as New Business, Virtual CEO Nerviano Medical Sciences S.r.l., a part of NMS Group S.p.A. (NMS Group), focused on the discovery and early development of oncology drugs and